Artificial Cells, Nanomedicine, and Biotechnology (Dec 2024)

The interdisciplinary approach to investigate bona fide agent(s) in flavonoids or alkaloids in treating HCC

  • Ki-Kwang Oh,
  • Sang-Jun Yoon,
  • Seol Hee Song,
  • Jeong Ha Park,
  • Jeong Su Kim,
  • Min Ju Kim,
  • Goo-Hyun Kwon,
  • Dong Joon Kim,
  • Ki-Tae Suk

DOI
https://doi.org/10.1080/21691401.2024.2413536
Journal volume & issue
Vol. 52, no. 1
pp. 500 – 511

Abstract

Read online

Currently, the treatment of hepatocellular carcinoma (HCC) is yet to be determined, alternatively, flavonoids or alkaloids from nature have been considered as significant mediators against HCC. In the scenario, we pioneered the most significant agent(s) in either flavonoid(s) or alkaloid(s) against HCC with cheminformatics, bioinformatics, computer screening tools and quantum chemistry concept. In prospect, the intent was to provide the theoretical scaffold in the myriad natural organic molecules. The cheminformatics (natural product activity & species source database (NPASS), SwissADME, PubChem, Similarity Ensemble Approach (SEA) and SwissTargetPrediction (STP)), bioinformatics (DisGeNET, OMIM and STRING) were employed to underpin promising therapeutic components. The protein–protein interaction (PPI) network to identify the relationships between each target and a bubble chart to elucidate key signalling pathway(s) was constructed via STRING database. Ultimately, computer screening tools (PyMOL and AutoDockTools 1.5.6) and quantum chemistry (GaussView 6 and Gaussian) concept were adopted to decrypt the key molecule(s), target(s) and key mechanism(s). The most significant target was AKT1 in PPI network, AKT1 – isorhamnetin, MCL1 – ochrindole D and PIM1 – heyneanine hydroxyindolenine were the most stable conformers to antagonize JAK–STAT signalling pathway. This study provides scientific manifestation to facilitate the clinical test despite the enormous complexity of herbal medicine, and the devised platform for further clarifying the bioactive(s) and mechanism(s) against HCC.

Keywords